Comparison of 111In-[DTPA0]Octreotide Versus Non Carrier Added 177Lu- [DOTA0,Tyr3]-Octreotate Efficacy in Patients With GEP-NET Treated Intra-arterially for Liver Metastases.
Limouris GS, Poulantzas V, Trompoukis N, Karfis I, Chondrogiannis S, Triantafyllou N, Gennimata V, Moulopoulou LE, Patsouris E, Nikou G, Michalaki V, Fragulidis G, Paphiti M, McCready RV, Colletti PM, Cook GJ, Rubello D.
Limouris GS, et al. Among authors: gennimata v.
Clin Nucl Med. 2016 Mar;41(3):194-200. doi: 10.1097/RLU.0000000000001096.
Clin Nucl Med. 2016.
PMID: 26673241